Stifel Financial’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-11,730
Closed -$391K 3032
2020
Q2
$391K Buy
11,730
+32
+0.3% +$1.02K ﹤0.01% 2195
2020
Q1
$318K Buy
+11,698
New +$326K ﹤0.01% 2144
2018
Q4
Sell
-21,933
Closed -$576K 2867
2018
Q3
$576K Sell
21,933
-52
-0.2% -$1.41K ﹤0.01% 2023
2018
Q2
$450K Sell
21,985
-163
-0.7% -$3.5K ﹤0.01% 2082
2018
Q1
$397K Buy
22,148
+324
+1% +$5.4K ﹤0.01% 2096
2017
Q4
$300K Sell
21,824
-7,402
-25% -$100K ﹤0.01% 2209
2017
Q3
$537K Sell
29,226
-3,396
-10% -$56.8K ﹤0.01% 1843
2017
Q2
$553K Buy
32,622
+9,813
+43% +$149K ﹤0.01% 1811
2017
Q1
$300K Sell
22,809
-2,818
-11% -$44.1K ﹤0.01% 2098
2016
Q4
$384K Sell
25,627
-100
-0.4% -$1.32K ﹤0.01% 1914
2016
Q3
$312K Sell
25,727
-724
-3% -$8.51K ﹤0.01% 1969
2016
Q2
$286K Buy
26,451
+3,236
+14% +$33.4K ﹤0.01% 2063
2016
Q1
$214K Buy
23,215
+8,007
+53% +$86.2K ﹤0.01% 1977
2015
Q4
$225K Buy
15,208
+2,527
+20% +$42.3K ﹤0.01% 2059
2015
Q3
$208K Sell
12,681
-4,003
-24% -$81.9K ﹤0.01% 2011
2015
Q2
$381K Buy
16,684
+4,512
+37% +$89.9K ﹤0.01% 1833
2015
Q1
$185K Buy
12,172
+836
+7% +$10.9K ﹤0.01% 2131
2014
Q4
$136K Buy
11,336
+222
+2% +$2.54K ﹤0.01% 2158
2014
Q3
$126K Sell
11,114
-126
-1% -$1.44K ﹤0.01% 2081
2014
Q2
$136K Buy
11,240
+38
+0.3% +$449 ﹤0.01% 2066
2014
Q1
$131K Buy
+11,202
New +$190K ﹤0.01% 1983

Other funds holding MNTA

Stifel Financial's MNTA Position: Q3 2020 in Review

Stifel Financial sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 11,730 shares — an estimated $391K sold.

Stifel Financial first reported a position in MNTA in Q1 2014 and held it in 21 quarters. The position peaked at $576K in Q3 2018. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Stifel Financial reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Stifel Financial sold 11,730 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $391K.
  • Stifel Financial first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 21 quarters.
  • Stifel Financial's Momenta Pharmaceuticals, Inc. position peaked at $576K in Q3 2018.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Stifel Financial's 13F filing for Q3 2020, filed 16 Nov 2020.